JP2001021559A - Pretreatment method for measuring protein-coupled saccharified protein by enzyme immunoassay - Google Patents

Pretreatment method for measuring protein-coupled saccharified protein by enzyme immunoassay

Info

Publication number
JP2001021559A
JP2001021559A JP11226780A JP22678099A JP2001021559A JP 2001021559 A JP2001021559 A JP 2001021559A JP 11226780 A JP11226780 A JP 11226780A JP 22678099 A JP22678099 A JP 22678099A JP 2001021559 A JP2001021559 A JP 2001021559A
Authority
JP
Japan
Prior art keywords
protein
reaction
enzyme
enzyme immunoassay
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11226780A
Other languages
Japanese (ja)
Other versions
JP3615428B2 (en
Inventor
Junichi Yano
潤一 矢野
Nobuhiko Mizukawa
暢彦 水川
Mikiko Nakajima
美貴子 中島
Miyuki Rai
美由紀 来
Hiroaki Miyatake
博昭 宮武
Tomoyoshi Hosokawa
知良 細川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fushimi Pharmaceutical Co Ltd
Original Assignee
Fushimi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fushimi Pharmaceutical Co Ltd filed Critical Fushimi Pharmaceutical Co Ltd
Priority to JP22678099A priority Critical patent/JP3615428B2/en
Publication of JP2001021559A publication Critical patent/JP2001021559A/en
Application granted granted Critical
Publication of JP3615428B2 publication Critical patent/JP3615428B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a pretreatment method for easily and accurately measuring a protein-coupled saccharified protein in a living body. SOLUTION: For this simple and quick pretreatment method, a proteolytic enzyme such as pronase or protinase-K is used, and an enzyme reaction is effected at a relatively high temperature (about 550 deg.C) so as to reduce the reaction time. In enzyme immunoassay, a pretreatment reagent is used in deactivating residual enzyme activity that may cause damage to an antibody and an antigen, by boiling in boiled water for about ten and several minutes. In the method, the time required to bring about a protein decomposition reaction by means of an enzyme and deactivate the enzyme is two hours or less, and a sample pretreated by the simple method in a short time can be put to precise analysis by anzyme immunoassay.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は蛋白糖化反応生成物
を蛋白分解酵素と短時間、高温で反応させ、さらに沸騰
水中で失活させる方法で前処理した検体を、酵素免疫法
に供することによって簡便かつ正確に生体内の蛋白結合
型糖化蛋白を測定するための前処理方法に関するもので
ある。
[0001] The present invention relates to a method of reacting a protein saccharification reaction product with a protease at a high temperature for a short time and then inactivating it in boiling water, and subjecting the specimen to enzyme immunoassay. The present invention relates to a pretreatment method for simply and accurately measuring a protein-bound glycated protein in a living body.

【0002】[0002]

【従来の技術】蛋白糖化反応はメイラードがアミノ酸と
還元糖を加熱すると黄褐色の色素が生成し、香りや保存
に影響を与えることを発見して以来、食品化学の分野で
は古くから重視されてきた。最近になって医学の領域で
も注目されるようになったのは蛋白糖化反応初期生成物
であるヘモグロビンA1cが血糖コントロールのマーカ
ーとして有用であることが明らかになるとともに、蛋白
糖化反応後期生成物(AGE)が腎症や糖尿病性合併症
の発症・進展に深くかかわっていることを示唆する学術
論文が発表されるようになってからである。初期反応生
成物としては、ヘモグロビンA1cの他にグリコアルブ
ミン、フルクトサミンが血糖コントロールの指標として
使用されており、その測定法についても高速液体クロマ
トグラフィー法、免疫学的測定法、比色法、アフィニテ
ィークロマトグラフィー法等がある。さらに、測定法に
よって検出する成分が異なることや、測定施設によって
測定値が変動することから糖尿病学会でも永年にわたっ
て標準化作業が行われている。後期反応生成物としては
ペントシジン、カルボキシメチルリジン、ピラリン、ク
ロスリン等が報告されており、これらの生成物の沈着と
各種組織障害との間には密接な相関性があることを強く
示唆する知見が多数、報告されている。ペントシジンは
アルツハイマー病患者の脳や腎不全患者の尿細管に沈着
していることが明らかにされており、また、慢性関節リ
ューマチ患者や腎不全患者の血中濃度が著しく上昇して
おり、その濃度は病態の進展と強い相関性が認められる
ことから、診断マーカーへの応用が期待されている。こ
れらの後期反応生成物は糖尿病患者の末梢神経、水晶
体、腎臓への沈着が認められることから、糖尿病性合併
症の発症・進展因子の一つとして注目され、血糖コント
ロールのみならず蛋白糖化反応生成物のコントロールが
合併症の発症予防につながるものと期待されている。そ
のためにも測定方法の確立は急務の課題といえるであろ
う。
2. Description of the Related Art Since the discovery that Maillard heats amino acids and reducing sugars to produce a yellow-brown pigment that affects fragrance and storage, protein saccharification has long been regarded as important in the field of food chemistry. Was. Recently, it has been noted in the medical field that hemoglobin A1c, which is an early product of a protein glycation reaction, has been revealed to be useful as a marker for controlling blood sugar, and that a late product of a protein glycation reaction ( Academic papers suggesting that AGEs are deeply involved in the development and progression of nephropathy and diabetic complications have been published. As an initial reaction product, glycoalbumin and fructosamine are used as indicators of blood glucose control in addition to hemoglobin A1c, and the measurement methods are also high performance liquid chromatography, immunological measurement, colorimetry, affinity chromatography. There is a photographic method. Furthermore, because the components to be detected differ depending on the measurement method and the measurement values vary depending on the measurement facility, the Diabetes Society has been standardizing the work for many years. Late reaction products such as pentosidine, carboxymethyl lysine, pyralin and croslin have been reported, and there is strong evidence strongly suggesting that there is a close correlation between the deposition of these products and various tissue disorders. Many have been reported. Pentosidine has been shown to be deposited in the brain of patients with Alzheimer's disease and in the tubules of patients with renal failure.In addition, the blood level of patients with rheumatoid arthritis and renal failure has been significantly increased. Is strongly correlated with the progress of the disease state, and is expected to be used as a diagnostic marker. Since these late-stage reaction products are found to be deposited on the peripheral nerves, lens, and kidneys of diabetic patients, they are attracting attention as one of the factors for the onset and progression of diabetic complications. It is expected that product control will lead to prevention of complications. Therefore, establishing a measurement method is an urgent issue.

【0003】後期反応生成物は生体内では蛋白と結合し
ているため、その測定には繁雑な前処理とあまり一般的
ではない測定機器が必要である。後期反応生成物のうち
唯一、定量法の確立しているペントシジンの場合、血漿
中の蛋白をトリクロロ酢酸で沈殿させ、2回洗浄後、窒
素ガス封入下、6N塩酸で110℃、17時間加水分解
する。その後、減圧下で塩酸を蒸発、乾固して除去し、
蒸留水で希釈して蛍光高速液体クロマトグラフィー法で
測定しなければならない。カルボキシメチルリジンの場
合でも血漿をペントシジンの場合と同様に蛋白を沈殿、
洗浄後、6N塩酸で加水分解し、塩酸を除去した後、ガ
スクロマトグラフィー/ガススペクトロメトリーで測定
する方法やアミノ酸分析機で測定する方法が報告されて
いる。
[0003] Since the late reaction products are bound to proteins in vivo, their measurement requires complicated pretreatments and less common measuring instruments. Among the late reaction products, only pentosidine, for which a quantitative method has been established, precipitates plasma proteins with trichloroacetic acid, and after washing twice, hydrolyzes with 6N hydrochloric acid at 110 ° C. for 17 hours under nitrogen gas filling. I do. After that, the hydrochloric acid was evaporated under reduced pressure, dried and removed,
It must be diluted with distilled water and measured by fluorescence high performance liquid chromatography. In the case of carboxymethyl lysine, plasma is precipitated as in the case of pentosidine,
After washing, hydrolysis with 6N hydrochloric acid and removal of hydrochloric acid, followed by measurement by gas chromatography / gas spectrometry or measurement by an amino acid analyzer have been reported.

【0004】後期反応生成物の測定には繁雑な前処理と
特殊な分析機器を必要とするため、簡便な酵素免疫法に
よる分析を目的として数多くの後期反応生成物に対する
ポリクローナル抗体やモノクローナル抗体が取得された
が、一部の抗体が免疫染色に利用されているに過ぎず、
酵素免疫測定法としては確立されていない。そのため蛋
白糖化反応生成物に関する研究は、その重要性が認識さ
れているにも拘わらず、限られた研究機関で研究が継続
されている状況である。抗体は取得されているにも拘わ
らず、酵素免疫測定法として確立されない最大の原因は
蛋白糖化後期反応生成物は生体内では蛋白分子とクロス
リンクしているため、酵素免疫系で測定するためには後
期反応生成物を蛋白分子表面に露出させるための前処理
が必要であるが、そのための簡便な方法が開発されてい
ないことにある。
Since the measurement of late reaction products requires complicated pretreatment and special analytical equipment, a large number of polyclonal and monoclonal antibodies against late reaction products have been obtained for the purpose of simple enzyme immunoassay analysis. However, only some antibodies are used for immunostaining,
It has not been established as an enzyme immunoassay. For this reason, research on protein saccharification reaction products is being conducted in a limited number of research institutes, despite its importance being recognized. Despite the fact that antibodies have been obtained, the biggest reason that enzyme immunoassay has not been established is that the late reaction product of protein glycation crosslinks with protein molecules in vivo, so it is necessary to measure with enzyme immunoassay. Pretreatment for exposing late reaction products to the surface of protein molecules is necessary, but a simple method for that purpose has not been developed.

【0005】[0005]

【発明が解決しようとする課題】蛋白に結合した後期反
応生成物を蛋白分子表面へ露出させるための方法に関し
ては加水分解法、蛋白分解酵素法、アルカリ処理法等が
報告されている。加水分解法については血漿蛋白を窒素
ガス封入下、6N塩酸、110℃で加水分解後3N炭酸
ナトリウムで中和し、さらにミクロフィルターで濾過し
た後、酵素免疫法で測定する方法が報告されている(ネ
フロロジイ、ダイアリイシイス、トランスプランテーシ
ョン14巻、576−580頁、1999年)。蛋白分
解酵素法については血漿蛋白を2%プロナーゼEで37
℃、24時間処理した後、プロナーゼEを遠心型メンブ
ランフィルターで除去した後、酵素免疫法で測定する方
法が報告されている(クリニカルケミストリー40巻、
1766−1773頁、1994年)。前者は液体クロ
マトグラフィー法の際の前処理方法と同じで、操作が繁
雑で加水分解反応に17時間を要し、その前後の処理に
も長時間を要する点、後者は酵素反応に24時間要し、
さらに、酵素を除去するために高価なフィルターを用い
る点から、両者ともに迅速性と処理量並びに簡便さに問
題があり、実用性に難点があることから、酵素免疫法に
供するまでの簡便かつ迅速な処理法が要望されていた。
With respect to methods for exposing late reaction products bound to proteins to the surface of protein molecules, hydrolysis methods, proteolytic enzyme methods, alkali treatment methods and the like have been reported. With regard to the hydrolysis method, a method has been reported in which plasma protein is hydrolyzed at 6 ° C. and 110 ° C. under nitrogen gas sealing, neutralized with 3N sodium carbonate, filtered through a microfilter, and then measured by enzyme immunoassay. (Nephrology, Dialyss, Transplantation 14, 576-580, 1999). For the proteolytic enzyme method, plasma proteins were treated with 2% pronase E at 37%.
C. for 24 hours, followed by removal of pronase E by a centrifugal membrane filter and measurement by enzyme immunoassay (Clinical Chemistry Vol. 40, vol.
1766-1773, 1994). The former is the same as the pretreatment method in the case of the liquid chromatography method. The operation is complicated and the hydrolysis reaction takes 17 hours, and the treatment before and after takes a long time. The latter takes 24 hours for the enzymatic reaction. And
Furthermore, both have problems in speed, throughput, and simplicity in that expensive filters are used to remove enzymes, and there are difficulties in practicality. There was a demand for a suitable processing method.

【0006】[0006]

【課題を解決するための手段】簡便かつ迅速な前処理法
として本発明は蛋白分解酵素を用いるが、その場合、最
も重要な課題は、蛋白に結合している蛋白糖化反応生成
物を蛋白分子表面に完全に露出させるための反応条件の
設定と、反応終了後の酵素を如何にして除去又は不活化
するかである。反応条件の設定は、酵素反応温度、反応
時間、酵素量並びに酵素除去法にかわる酵素失活法につ
いて検討を行った。これらの検討は迅速性と簡便性を要
求される診断薬の開発においては必須の条件である。な
お、酵素反応の検定は本特許の発明者らが開発した抗ペ
ントシジン−ウサギポリクローナル抗体並びに抗カルボ
キシメチルリジン−ウサギポリクローナル抗体による競
合酵素免疫法と高速液体クロマトグラフィー法で行っ
た。
The present invention uses a protease as a simple and rapid pretreatment method. In this case, the most important problem is to convert a protein saccharification reaction product bound to a protein into a protein molecule. It is the setting of reaction conditions for complete exposure to the surface, and how to remove or inactivate the enzyme after the reaction. Regarding the setting of reaction conditions, an enzyme reaction temperature, a reaction time, an amount of the enzyme, and an enzyme inactivation method instead of the enzyme removal method were examined. These studies are indispensable conditions in the development of diagnostic agents that require rapidity and simplicity. The enzyme reaction was assayed by a competitive enzyme immunoassay using an anti-pentosidine-rabbit polyclonal antibody and an anti-carboxymethyl lysine-rabbit polyclonal antibody developed by the inventors of the present invention and a high performance liquid chromatography method.

【0007】抗ペントシジン抗体はリジン、アルギニ
ン、リボースを成分とする反応液を2カ月間培養し、イ
オン交換樹脂クロマトグラフィー、ゲル濾過で分取し
た。ペントシジン画分を高速液体クロマトグラフィーで
分取して精製したペントシジンをキャリア蛋白質と結合
させた後、ウサギに投与し8週間後に屠殺して得た抗血
清をアフィニティクロマトグラフィーで精製して抗体を
取得した。抗カルボキシメチルリジン抗体は、ほう酸緩
衝液にシアン化ホウ酸ナトリウム、キャリア蛋白質を溶
解し、氷冷下で撹拌しながらグリオキシル酸溶液を添加
して作成したカルボキシメチルリジンをウサギに投与
し、8週間後に屠殺して得た抗血清から抗体を得た。抗
ペントシジン抗体、抗カルボキシメチルリジン抗体とも
に競合法による酵素免疫測定系を確立して蛋白分解酵素
の反応の検定に用いた。
[0007] The anti-pentosidine antibody was obtained by culturing a reaction solution containing lysine, arginine and ribose for 2 months, and separating it by ion exchange resin chromatography and gel filtration. The pentosidine fraction was collected by high performance liquid chromatography and purified, and the pentosidine was bound to the carrier protein, and then administered to rabbits. After 8 weeks, the antiserum obtained by sacrifice was purified by affinity chromatography to obtain antibodies. did. Anti-carboxymethyl lysine antibody was prepared by dissolving sodium cyanide borate and carrier protein in borate buffer, and adding a glyoxylic acid solution while stirring under ice-cooling to administer carboxymethyl lysine to rabbits for 8 weeks. Antibodies were obtained from the antiserum obtained by sacrifice later. For both anti-pentosidine antibody and anti-carboxymethyl lysine antibody, an enzyme immunoassay system was established by a competitive method and used for assaying the reaction of proteolytic enzymes.

【0008】高速液体クロマトグラフィー法による検定
は以下に示す方法で行った。トリクロロ酢酸を添加して
得た血漿中の蛋白を減圧乾固し、6N塩酸を添加し、窒
素置換後、120℃で24時間、加水分解した。さらに
減圧乾燥し蒸留水で再溶解して、高速液体クロマトグラ
フィー用のサンプルとした。高速液体クロマトグラフィ
ーによる分析は移動相はメタノール/7mMリン酸緩衝
液=1/99、カラムはODS−80TM,蛍光波長は
励起波長335nm、蛍光波長385nmの測定条件で
行った。
[0008] The assay by high performance liquid chromatography was carried out by the following method. The protein in the plasma obtained by adding trichloroacetic acid was evaporated to dryness under reduced pressure, 6N hydrochloric acid was added, the mixture was purged with nitrogen, and then hydrolyzed at 120 ° C. for 24 hours. Further, it was dried under reduced pressure and redissolved in distilled water to obtain a sample for high performance liquid chromatography. Analysis by high performance liquid chromatography was performed under the following measurement conditions: mobile phase: methanol / 7 mM phosphate buffer = 1/99, column: ODS-80TM, fluorescence wavelength: excitation wavelength 335 nm, fluorescence wavelength: 385 nm.

【0009】 蛋白に結合して存在する蛋白糖化反応生
成物を蛋白分子の表面に露出させるための手段として蛋
白分解酵素を使用した。蛋白分解酵素としては血漿から
抽出して製造されるプラスミン、プラスミラーゲン、ト
ロンビン等と微生物から抽出して製造されるプロナー
ゼ、プロティナーゼK等の蛋白分解酵素知られている。
通常、これらの酵素の反応温度は37℃であるが、反応
を短時間で行うために塩化カルシウムを含有するトリス
塩酸緩衝液に酵素と血漿、尿等の生体試料を添加して高
温下(50−60℃)で反応を行った。高温下で反応さ
せることによって通常、一昼夜を要していた分解反応を
わずか、1−3時間で蛋白糖化反応生成物を蛋白分子の
表面に完全に露出させることが可能になった。
As a means for exposing a protein saccharification reaction product present by binding to a protein to the surface of a protein molecule, a protease was used. Known proteolytic enzymes are plasmin, plasminogen, thrombin, etc., which are produced by extracting from plasma, and pronase, proteinase K, etc., which are produced by extracting from microorganisms.
Usually, the reaction temperature of these enzymes is 37 ° C. However, in order to carry out the reaction in a short time, the enzymes and a biological sample such as plasma and urine are added to a Tris-HCl buffer containing calcium chloride, and the reaction is carried out at high temperature (50 (−60 ° C.). By reacting at a high temperature, it became possible to completely expose the product of the protein saccharification reaction to the surface of the protein molecule in only 1-3 hours from the decomposition reaction which usually required one day and night.

【0010】蛋白分解酵素自身が抗体に影響を与えるた
め、反応終了後の蛋白分解酵素を除去又は不活化しなけ
ればならない。その方法としては、例えば、限外濾過膜
を装着したミクロチューブを用いて高速遠心分離によっ
て酵素を除去する方法があるが、これらの製品は高価で
あり、かつ、血漿中の蛋白量によっては遠心分離では完
全には除去できないことがあり、その場合、酵素免疫法
による測定において測定値にバラツキを生ずる原因とな
る。これに対して、沸騰水中(95℃以上)での加熱に
より短時間(5−15分間)で容易に酵素を失活させる
ことが可能である。加熱後の反応液と抗体との競合反応
を行う際にも、界面活性剤等の蛋白変性剤では、抗体へ
の影響が憂慮されるため4℃で長時間反応を行う必要が
あるが、本発明では競合反応は37℃、1時間でも目的
を達することが可能であり、酵素免疫測定系に用いた際
にも、測定値になんら影響を与えない。
Since the protease itself affects the antibody, the protease must be removed or inactivated after the reaction. For example, there is a method in which enzymes are removed by high-speed centrifugation using a microtube equipped with an ultrafiltration membrane.However, these products are expensive, and depending on the amount of protein in plasma, centrifugation is required. In some cases, it cannot be completely removed by separation, and in this case, it causes variation in measured values in the enzyme immunoassay. On the other hand, the enzyme can be easily deactivated in a short time (5 to 15 minutes) by heating in boiling water (95 ° C. or higher). When performing a competitive reaction between the reaction solution after heating and the antibody, it is necessary to perform the reaction at 4 ° C. for a long time with a protein denaturing agent such as a surfactant because the influence on the antibody is concerned. In the present invention, the competitive reaction can achieve its purpose even at 37 ° C. for 1 hour, and does not affect the measured value at all even when used in an enzyme immunoassay system.

【0011】[0011]

【発明の実施の形態】最終濃度が10−50mg/ml
の蛋白分解酵素と塩化カルシウムを含有するトリス塩酸
緩衝液並びに蒸留水に血漿等の生体試料を加えた反応液
を高温、短時間で反応させ、失活させた後、酵素免疫法
に供する。本発明において高温、短時間とは通常の反応
温度に比べてより高温の50−60℃、好ましくは55
℃のウォーターバス中で1−3時間、反応を行う。酵素
失活のための処理条件は酵素反応終了後、直ちに例え
ば、80℃以上、望ましくは95℃以上の沸騰水中に浸
して失活させる。その後、エチレンジアミン4酢酸を加
えて、過剰のカルシウムをキレート化させて、酵素免疫
測定系に供することによって、簡便かつ迅速に蛋白に結
合した糖化蛋白を測定することが可能である。また、上
記の反応系から生体試料を除く蛋白分解酵素と塩化カル
シウムを含有するトリス塩酸緩衝液からなる反応液をあ
らかじめ凍結乾燥しておき、使用時に蒸留水と生体試料
を添加して使用することも可能である。
DETAILED DESCRIPTION OF THE INVENTION Final concentration of 10-50 mg / ml
A reaction solution obtained by adding a biological sample such as plasma to a Tris-HCl buffer solution containing proteolytic enzyme and calcium chloride and distilled water is allowed to react at a high temperature for a short time, inactivated, and then subjected to enzyme immunization. In the present invention, the term “high temperature, short time” means 50-60 ° C., preferably 55 ° C., which is higher than the normal reaction temperature.
Perform the reaction for 1-3 hours in a water bath at ℃ C. Immediately after the completion of the enzymatic reaction, the enzyme is inactivated by immersing it in boiling water at 80 ° C. or higher, preferably 95 ° C. or higher. Thereafter, excess calcium is chelated by adding ethylenediaminetetraacetic acid, and then subjected to an enzyme immunoassay system, whereby glycated protein bound to the protein can be easily and quickly measured. In addition, a reaction solution consisting of a protease and a Tris-HCl buffer containing calcium chloride excluding the biological sample from the above reaction system is freeze-dried in advance, and distilled water and a biological sample are added before use. Is also possible.

【0012】[0012]

【実施例】以下に本発明を実施例に基づいて詳細に説明
するが、これらは本発明を何ら限定するものではない。
EXAMPLES The present invention will be described below in detail with reference to examples, but these examples do not limit the present invention in any way.

【0013】[0013]

【実施例1】小型の蓋付き試験管に20mg/ml又は
40mg/mlの濃度のプロティナーゼKあるいはプロ
ナーゼに塩化カルシウムを含むトリス塩酸緩衝液並びに
血漿を加えて300μlとし、0.5、2.0時間、5
5℃でインキュベートし、試験管を10分間、煮沸して
反応を停止させた。反応停止液中のペントシジンを競合
酵素免疫法で測定した結果を表−1に示した。 両方の酵素とも血中の蛋白を分解し、血中のペントシジ
ンを酵素免疫法で測定することが可能であった。
Example 1 A small test tube with a lid was added with Tris-HCl buffer containing 20 mg / ml or 40 mg / ml proteinase K or Tris-HCl buffer solution containing calcium chloride in pronase and plasma to make 300 μl, 0.5, 2.0 Time 5
After incubation at 5 ° C., the reaction was stopped by boiling the tubes for 10 minutes. Table 1 shows the results of measuring pentosidine in the reaction stop solution by the competitive enzyme immunoassay. Both enzymes decomposed blood proteins, and it was possible to measure pentosidine in blood by enzyme immunoassay.

【0014】[0014]

【実施例2】10,20,30mg/mlの濃度のプロ
ナーゼに塩化カルシウムを含むトリス塩酸緩衝液並びに
血漿を加えて300μlとし、0.5,1.0,1.
5,3.0,5.0時間、55℃でインキュベートし、
10分間、煮沸して反応を停止させた。また、比較のた
めに10mg/ml反応温度37oで同時間、反応さ
せた。反応停止液中のペントシジンを競合酵素免疫法で
測定した結果を表−2に示した。 プロナーゼ濃度10−30mg/ml、反応時間1.5
−3.0時間、反応温度55oCで分解反応がほぼ10
0%進行しているが、反応温度37oCでは反応途中
で、さらに長時間の反応が必要であることが明らかにな
った。
Example 2 Tris-HCl buffer containing calcium chloride and plasma were added to pronase at concentrations of 10, 20, and 30 mg / ml to make 300 μl, and 0.5, 1.0, 1.
Incubate at 55 ° C. for 5, 3.0, 5.0 hours,
The reaction was stopped by boiling for 10 minutes. For comparison, the reaction was carried out at a reaction temperature of 10 mg / ml at 37 ° C. for the same time. Table 2 shows the results of measuring pentosidine in the reaction stop solution by the competitive enzyme immunoassay. Pronase concentration 10-30 mg / ml, reaction time 1.5
-Decomposition reaction is approximately 10 hours at a reaction temperature of 55 ° C for 3.0 hours.
Although the reaction progressed by 0%, it became clear that a longer reaction was required during the reaction at a reaction temperature of 37 ° C.

【0015】[0015]

【実施例3】蛋白分解酵素の活性が残存した状態では酵
素免疫系に影響を与えるため蛋白分解酵素を除去又は失
活させることが必須である。そこで加熱による失活の条
件検討を行った。プロナーゼ10mg/mlと塩化カル
シウムを含むトリス塩酸緩衝液と生理食塩水を添加した
反応液の入った試験管を沸騰水(95oC)に0,1
0,20,30,40,60分間漬けて反応を停止させ
た。反応停止液を競合酵素免疫系に添加して反応を行
い、生理食塩水をブランクとして抗原−抗体反応系に対
する影響を検討した。結果を表−3に示した。 プロナーゼの蛋白分解活性は沸騰水中に10−30分間
漬けることによって、失活し、抗原−抗体系には影響を
与えないことが明らかになった。
Example 3 In a state in which the activity of the protease is remaining, it affects the enzyme immune system. Therefore, it is essential to remove or inactivate the protease. Therefore, the condition of deactivation by heating was examined. A test tube containing a reaction solution to which Tris-HCl buffer solution containing pronase 10 mg / ml and calcium chloride and a physiological saline solution were added was placed in boiling water (95 ° C) at 0,1.
The reaction was stopped by soaking for 0, 20, 30, 40 and 60 minutes. The reaction stop solution was added to the competitive enzyme immune system to carry out the reaction, and the effect on the antigen-antibody reaction system was examined using physiological saline as a blank. The results are shown in Table-3. It was revealed that the proteolytic activity of pronase was inactivated by immersion in boiling water for 10-30 minutes and had no effect on the antigen-antibody system.

【0016】[0016]

【実施例4】各10名の健常者、慢性腎不全患者、末期
腎不全患者の血漿中のペントシジンとカルボキシメチル
リジンを競合酵素免疫法で測定した。各血漿と塩化カル
シウムを含むトリス塩酸緩衝液とプロナーゼ10mg/
mlからなる反応液を1.5時間、55℃でインキュベ
ートした後、沸騰水中(15分間)で反応を停止させ
た。反応停止液を各抗原を固相した96穴のプレートに
添加して、それぞれにウサギポリクローナル抗体を加え
て酵素免疫反応を行い、マイクロプレートリーダー、波
長450nm/630nmで測定した。結果を表−4に
示した。 血漿中のペントシジン、カルボキシメチルリジン値はと
もに腎機能の低下に伴って著しく上昇していた。すなわ
ち、血漿中の蛋白結合型の糖化蛋白は血漿を蛋白分解酵
素で短時間(反応停止を含めても105分)前処理する
ことによって、酵素免疫法による測定が可能であること
が明らかになった。
Example 4 Pentosidine and carboxymethyl lysine in the plasma of 10 healthy subjects, chronic renal failure patients and end-stage renal failure patients were measured by competitive enzyme immunoassay. Tris-HCl buffer containing each plasma, calcium chloride and pronase 10mg /
After incubating 1.5 ml of the reaction solution at 55 ° C. for 1.5 hours, the reaction was stopped with boiling water (15 minutes). The reaction stop solution was added to a 96-well plate on which each antigen was immobilized, and a rabbit polyclonal antibody was added to each plate to carry out an enzyme immunoreaction. The measurement was performed using a microplate reader at a wavelength of 450 nm / 630 nm. The results are shown in Table-4. Both the levels of pentosidine and carboxymethyllysine in plasma increased markedly with a decrease in renal function. That is, it becomes clear that the protein-linked glycated protein in plasma can be measured by enzyme immunoassay by pretreating the plasma with proteolytic enzyme for a short time (105 minutes including reaction termination). Was.

【0017】[0017]

【発明の効果】本発明は生体内で蛋白に結合して存在す
る蛋白糖化反応生成物をプロナーゼ、プロティ ナーゼ
K等の蛋白分解酵素を用いて、通常(37℃)よりも高
温(55℃)で、短時間(30−120分間)処理し、
その後、沸騰水中で失活させることによって血漿、尿等
に含まれる蛋白糖化反応生成物を酵素免疫法で簡便に測
定することを目的としている。本発明の方法で前処理し
た検体を酵素免疫法で測定した血漿中ペントシジン値
は、高速液体クロマトグラフィー法で測定した値と高い
相関性を示し、また、両者の方法による測定値は近似し
ていた。また、本発明の方法で測定した血漿中のペント
シジン値は例えば、腎機能の低下した患者では著しく上
昇しており、血漿クレアチニン値とは高い相関性を示し
ており、腎症の診断に有用である。
According to the present invention, a protein saccharification reaction product which is present in a living body by binding to a protein is heated to a higher temperature (55 ° C.) than normal (37 ° C.) using a protease such as pronase or proteinase K. For a short time (30-120 minutes)
Thereafter, the objective is to easily measure a protein saccharification reaction product contained in plasma, urine, or the like by enzyme immunization by inactivating in boiling water. The plasma pentosidine value measured by the enzyme immunoassay of the sample pretreated by the method of the present invention shows a high correlation with the value measured by the high performance liquid chromatography method, and the measured values by both methods are close to each other. Was. Further, the pentosidine value in plasma measured by the method of the present invention, for example, is significantly increased in patients with reduced renal function, shows a high correlation with plasma creatinine value, useful for the diagnosis of nephropathy is there.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 中島 美貴子 徳島県徳島市応神町吉成104番地 株式会 社伏見製薬所徳島工場内 (72)発明者 来 美由紀 徳島県徳島市応神町吉成104番地 株式会 社伏見製薬所徳島工場内 (72)発明者 宮武 博昭 東京都中央区明石町1番29号 ファミール 築地202号 伏見製薬株式会社築地分室内 (72)発明者 細川 知良 徳島県徳島市応神町吉成104番地 株式会 社伏見製薬所徳島工場内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Mikiko Nakajima 104, Yoshinari, Ojin-cho, Tokushima, Tokushima Pref. Inside the Fushimi Pharmaceutical Works Tokushima Plant (72) Inventor Hiroaki Miyatake 1-29 Akashi-cho, Chuo-ku, Tokyo Famille Tsukiji 202 Fushimi Pharmaceutical Co., Ltd.Tsukiji Branch (72) Inventor Tomoyoshi Hosokawa 104 Address Co., Ltd.Fushimi Pharmaceutical Works Tokushima Plant

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】蛋白に結合して存在する蛋白糖化反応生成
物を測定するに際して、検体と蛋白分解酵素を短時間、
高温で反応させ、失活させた後、酵素免疫法に供するこ
とを特徴とする検体の前処理方法。
1. A method for measuring a protein saccharification reaction product present by binding to a protein, comprising:
A pretreatment method for a specimen, comprising reacting at a high temperature and inactivating it, and then subjecting it to an enzyme immunoassay.
JP22678099A 1999-07-07 1999-07-07 Pretreatment method for measuring protein-bound glycated protein by enzyme immunoassay Expired - Lifetime JP3615428B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22678099A JP3615428B2 (en) 1999-07-07 1999-07-07 Pretreatment method for measuring protein-bound glycated protein by enzyme immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22678099A JP3615428B2 (en) 1999-07-07 1999-07-07 Pretreatment method for measuring protein-bound glycated protein by enzyme immunoassay

Publications (2)

Publication Number Publication Date
JP2001021559A true JP2001021559A (en) 2001-01-26
JP3615428B2 JP3615428B2 (en) 2005-02-02

Family

ID=16850505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22678099A Expired - Lifetime JP3615428B2 (en) 1999-07-07 1999-07-07 Pretreatment method for measuring protein-bound glycated protein by enzyme immunoassay

Country Status (1)

Country Link
JP (1) JP3615428B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011516882A (en) * 2008-04-10 2011-05-26 デナトール アクティエボラグ Device for storing and preparing biological samples
WO2021039611A1 (en) * 2019-08-27 2021-03-04 キッコーマン株式会社 Method for measuring pentosidine and measurement kit
US11932880B2 (en) 2018-02-27 2024-03-19 Kikkoman Corporation Enzyme and method for assaying pentosidine using same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011516882A (en) * 2008-04-10 2011-05-26 デナトール アクティエボラグ Device for storing and preparing biological samples
US11932880B2 (en) 2018-02-27 2024-03-19 Kikkoman Corporation Enzyme and method for assaying pentosidine using same
WO2021039611A1 (en) * 2019-08-27 2021-03-04 キッコーマン株式会社 Method for measuring pentosidine and measurement kit
EP4023754A4 (en) * 2019-08-27 2023-09-27 Kikkoman Corporation Method for measuring pentosidine and measurement kit

Also Published As

Publication number Publication date
JP3615428B2 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
EP1867659A1 (en) Antibody reactive specifically to age derived from 3,4-dge
EP1898215B1 (en) Method of assaying endocrine substance in specimen
JP3579549B2 (en) Use as a marker for diabetes or diabetic complications
US20230393042A1 (en) Pretreatment method, preservation method, automatic treatment system and detection method for urine sample
CA2633912A1 (en) Distinction between bacterial meningitis and viral meningitis
CN115184517A (en) Online derivatization detection method for plasma amino acid
JP4183116B2 (en) Calibration material for glycated protein measurement and standard measurement method
JPH08228795A (en) Preparation of sample for analyzing saccharide chain and diagnosis using the same sample
JPH0474669B2 (en)
JP2001021559A (en) Pretreatment method for measuring protein-coupled saccharified protein by enzyme immunoassay
JP4622836B2 (en) Analysis equipment
JP4847668B2 (en) Method for detecting glycated albumin
JP5069023B2 (en) Calibration material for glycated protein measurement and standard measurement method
CN112269021A (en) IgM quality control product and preparation method thereof
FR2508646A1 (en) METHOD AND EQUIPMENT FOR THE DETERMINATION OF GLYCOSYLATED PROTEINS IN BIOLOGICAL FLUIDS
EP0762121A1 (en) Antigen for enzyme immunoassay and method of measuring anti-erythrocyte antibody
FR3096459A1 (en) Process for preparing a peptide sample
JP3614849B2 (en) Pretreatment agent, pretreatment method, measurement method using pretreated sample, measurement kit and sample determination method
JP3898618B2 (en) Determination of anticoagulant factor antibody by enzyme immunoassay
JPH0630791A (en) Quantification of saccharified protein
SU584849A1 (en) Method of diagnosis of rejection crisis at allotransplantation of kidneys
RU2235329C1 (en) METHOD FOR DETERMINATION OF FUNCTIONAL ACTIVITY OF C1r2s2 SUBCOMPONENTS OF THE FIRST HUMAN COMPLEMENT COMPONENT
SU1532877A1 (en) Method of quantitative analysis of polypeptoid components of average molecular mass in blood
JP3481015B2 (en) Immunoturbidimetry
CN118464760A (en) Staining buffer solution and detection kit for detecting CD42b by flow cytometry and preparation and use methods thereof

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040722

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040722

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041029

R150 Certificate of patent or registration of utility model

Ref document number: 3615428

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071112

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081112

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091112

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101112

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101112

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111112

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111112

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121112

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131112

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term